Hi Greg
I missed too. The report is very bullish, calling FY24 a watershed year for PAC.
Guidance is only that multiple suitors are being pursued with submissions expected to be received by mid-September. After this PAC will enter exclusive due diligence with party.
This could mean that Regal/River Capital need to consider increasing bid before this stage to get to final round.
Fair value at $11.92 might see slight increase in offer, but current shareholders miss out on FY24 upside. This is what we have all been hanging on for.
- Forums
- ASX - By Stock
- PAC
- Ann: FY23 Results Presentation and Managing Director's Overview
Ann: FY23 Results Presentation and Managing Director's Overview, page-4
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.71 |
Change
0.070(0.66%) |
Mkt cap ! $559.0M |
Open | High | Low | Value | Volume |
$10.75 | $10.84 | $10.67 | $532.0K | 49.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 399 | $10.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.77 | 240 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 399 | 10.710 |
1 | 240 | 10.700 |
1 | 240 | 10.690 |
1 | 240 | 10.680 |
1 | 900 | 10.550 |
Price($) | Vol. | No. |
---|---|---|
10.770 | 240 | 1 |
10.780 | 240 | 1 |
10.790 | 240 | 1 |
10.830 | 500 | 1 |
10.900 | 5000 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online